Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.23% is 26% below its 5-year average of 3.02%, around the middle of its 5-year range (0.56%–5.26%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.27% below its 12-month average of 2.35%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.23%.
DEBT TO ASSETS RATIO
2.23%
DEBT TO ASSETS RATIO AVG TTM
2.35%
DEBT TO ASSETS RATIO AVG 3Y
2.51%
DEBT TO ASSETS RATIO AVG 5Y
3.02%
DEBT TO ASSETS RATIO AVG 10Y
7.88%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.27%
CURRENT VS 3Y AVG
-11.34%
CURRENT VS 5Y AVG
-26.11%
CURRENT VS 10Y AVG
-71.71%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+2376.22%
vs the sector median at left
enVVeno Medical Corporation
Market Cap
$5.66M
Debt to Assets Ratio
2.23%
TTM Avg
2.35%
3Y Avg
2.51%
5Y Avg
3.02%
Market Cap
$5.60M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.59M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.74M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.79M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.92M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.97M
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| enVVeno Medical Corporation (NVNO) | $5.66M | 2.23% | 2.35% | 2.51% | 3.02% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.60M | 0.06% | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | 0.00% | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.74M | 0.00% | N/A | N/A | N/A |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.79M | 0.04% | N/A | N/A | N/A |
| Lucyd, Inc (LUCY)vs › | $5.82M | 0.01% | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.92M | 0.05% | N/A | N/A | N/A |
| Scienture Holdings, Inc. (SCNX)vs › | $5.97M | 0.12% | N/A | N/A | N/A |
| Soligenix, Inc. (SNGX)vs › | $5.34M | 0.03% | N/A | N/A | N/A |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.27M | 0.15% | N/A | N/A | N/A |
Debt/Assets
2.2%
Debt/Equity
0.02
Current Ratio
11.70
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.23% |
| 2026-03-31 | 2.31% |
| 2025-12-31 | 2.37% |
| 2025-09-30 | 2.44% |
| 2025-06-30 | 2.41% |
| 2025-03-31 | 2.41% |
| 2024-12-31 | 2.37% |
| 2024-09-30 | 2.28% |
| 2024-06-30 | 3.01% |
| 2024-03-31 | 2.94% |
| 2023-12-31 | 2.88% |
| 2023-09-30 | 5.26% |
| 2023-06-30 | 4.86% |
| 2023-03-31 | 4.47% |
| 2022-12-31 | 4.12% |
| 2022-09-30 | 3.94% |
| 2022-06-30 | 3.73% |
| 2022-03-31 | 3.57% |
| 2021-12-31 | 3.48% |
| 2021-09-30 | 0.56% |
| 2021-06-30 | 1.71% |
| 2021-03-31 | 1.78% |
| 2020-12-31 | 8.36% |
| 2020-09-30 | 13.53% |
| 2020-06-30 | 27.45% |
| 2020-03-31 | 28.53% |
| 2019-12-31 | 24.94% |
| 2019-09-30 | 16.05% |
| 2019-06-30 | 13.64% |
| 2019-03-31 | 19.23% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 167.75% |
| 2017-12-31 | 118.24% |
| 2017-09-30 | 86.43% |
| 2017-06-30 | 59.97% |
| 2016-12-31 | 35.49% |
| 2016-09-30 | 23.32% |
| 2015-12-31 | 63.69% |
